547 related articles for article (PubMed ID: 24565772)
1. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
[TBL] [Abstract][Full Text] [Related]
2. The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond.
Russell N; Jennings S; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1157-1165.e6. PubMed ID: 30098409
[TBL] [Abstract][Full Text] [Related]
3. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
4. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
5. Patient Perceptions in Mast Cell Disorders.
Jennings SV; Slee VM; Zack RM; Verstovsek S; George TI; Shi H; Lee P; Castells MC
Immunol Allergy Clin North Am; 2018 Aug; 38(3):505-525. PubMed ID: 30007467
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
8. Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Severino M; Chandesris MO; Barete S; Tournier E; Sans B; Laurent C; Apoil PA; Lamant L; Mailhol C; Laroche M; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C
J Am Acad Dermatol; 2016 May; 74(5):885-91.e1. PubMed ID: 26899198
[TBL] [Abstract][Full Text] [Related]
9. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
Picard M; Giavina-Bianchi P; Mezzano V; Castells M
Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
[TBL] [Abstract][Full Text] [Related]
10. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
[TBL] [Abstract][Full Text] [Related]
12. Telangiectasia macularis eruptiva perstans presented as a pseudoallergic food reaction.
Vidal C; del Rio E; Suárez-Peñaranda J; Armisén M
J Investig Allergol Clin Immunol; 2000; 10(4):248-50. PubMed ID: 11039843
[TBL] [Abstract][Full Text] [Related]
13. Mast cell activation syndromes presenting as anaphylaxis.
Akin C
Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
[TBL] [Abstract][Full Text] [Related]
14. Dermatoscopic findings of cutaneous mastocytosis.
Akay BN; Kittler H; Sanli H; Harmankaya K; Anadolu R
Dermatology; 2009; 218(3):226-30. PubMed ID: 19060465
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous mastocytosis in Singapore.
Tay YK; Giam YC
Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
[TBL] [Abstract][Full Text] [Related]
16. Clinical varieties of mastocytoses.
Puretić S; Milavec D
Acta Med Croatica; 2001; 55(2):61-6. PubMed ID: 11505629
[TBL] [Abstract][Full Text] [Related]
17. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
[TBL] [Abstract][Full Text] [Related]
18. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
Turchin I; Barankin B; Schloss E
Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
[TBL] [Abstract][Full Text] [Related]
19. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
[TBL] [Abstract][Full Text] [Related]
20. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM; Torrelo A; Matito A
Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
